Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) Shareholder Notice: Lawsuit Against Acquisition Filed
An investor who currently holds shares of Kythera Biopharmaceuticals Inc (NASDAQ:KYTH), filed a lawsuit in effort to halt the proposed takeover of Kythera Biopharmaceuticals Inc by Allergan plc for a value of $75 per share is unfair to NASDAQ:KYTH stockholders.
View full press release